CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. FDA Record
- Latest inspection VAI · Mar 21, 2025
- No warning letters matched by name
CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. has 0 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd." is on file.
- Latest inspection
- Mar 21, 2025 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 3 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Mar 21, 2025 | Shijiazhuang, China | Drugs | Voluntary Action Indicated (VAI) | 3008929107 |
| Sep 4, 2019 | Shijiazhuang, China | Drugs | No Action Indicated (NAI) | 3008929107 |
| Nov 7, 2013 | Shijiazhuang, China | Drugs | Voluntary Action Indicated (VAI) | 3008929107 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3008929107 | Shijiazhuang, China | 3 | Mar 21, 2025 |
CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. and the FDA: common questions
Has CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. received an FDA warning letter?
No FDA warning letter addressed to the name "CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. received an FDA Form 483?
FDA has not published a Form 483 for "CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd.?
The most recent FDA inspection on file ended Mar 21, 2025 at Shijiazhuang, China and was classified VAI. FDA has 3 inspections of CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. on file.
Need more than this page shows? Ask about CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.